Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-01-24
2006-01-24
Saoud, Christine J. (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S909000, C530S399000, C530S350000, C930S010000
Reexamination Certificate
active
06989367
ABSTRACT:
The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight gain in animals. This compound should be effective for reducing body mass and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
REFERENCES:
patent: 5270170 (1993-12-01), Schatz et al.
patent: 5635373 (1997-06-01), Wozney et al.
patent: 5869330 (1999-02-01), Scherrer et al.
patent: 6126939 (2000-10-01), Eisenbach-Schwartz et al.
patent: 6197930 (2001-03-01), Sheppard et al.
patent: 6344441 (2002-02-01), Bihain et al.
patent: 6635431 (2003-10-01), Bihain et al.
patent: 2002/0165154 (2002-11-01), Bihain et al.
patent: 1 033 134 (2000-09-01), None
patent: 1033134 (2000-09-01), None
patent: WO 96/30400 (1996-10-01), None
patent: WO 96/34981 (1996-11-01), None
patent: WO 96/39429 (1996-12-01), None
patent: WO 97/27285 (1997-07-01), None
patent: WO 97/27286 (1997-07-01), None
patent: WO 98/01257 (1998-01-01), None
patent: WO 98/20165 (1998-05-01), None
patent: WO 98/54311 (1998-12-01), None
patent: WO 99/07736 (1999-02-01), None
patent: WO 99/07737 (1999-02-01), None
patent: WO 99/10492 (1999-03-01), None
patent: WO 99/21577 (1999-05-01), None
patent: WO 99/21577 (1999-05-01), None
patent: WO 99/21577 (1999-06-01), None
U.S. Appl. No. 10/650,507, Bihain et al., filed Aug. 27, 2003.
U.S. Appl. No. 10/072,159, Bihain et al., filed Feb. 25, 2002.
Groenen, P. et al. “Structure, Sequence and Chromosome 19 Localization of Human USF2 and Its Rearrangement in a Patient with Multicystic Renal Adysplasia”,Genomics, 1995, pp. 141-148, vol. 38, XP002067467.
Bihain, B. et al. “The Lypolysis-Stimulated Receptor; A Gene At Last”,Current Opinion in Liodology, 1998, pp. 221-224, vol. 9, No. 3.
Das, K. et al. “Chromosomal Localizations, Expression Pattern, and Promoter Analysis of the Mouse Gene Encoding Adipocye-Specific Secretory Protein ACRP30”,Biochem. and Biophys. Res. Comm., 2001, pp. 1120-1129, vol. 280, Academic Press.
Dietrich, J. et al. “CD3y Contains a Phosphoserine-Dependent Di-Leucine Motif Involved in Down-Regulation of the T Cell Receptor,”EMBO Journal, 1994, pp. 2156-2166, vol. 13.
Van Den Berg, R.H., et al. “Intracellular Localization of the Human Receptor for the Globular Domains of C1q,”Journal of Immunology, 1997, pp. 3909-3916, vol. 158.
Lamerdin, J. E. “Homo Sapiens DNA From Chromosome 19-Cosmid R30879 Containing USF2, Genomic Sequence”,EMBL Sequence Database, 1997, XP002096567.
Alexeev and Yoon, “Stable and Inheritable Changes in Genotype and Phenotype of Albino Melanocytes Induced by an RNA-DNA Oligonucleotide”: Nature Biotech. 16:1343-1346, 1998.
Arita, et al., “Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity”, Biochem. and Biophys. Research Comm. 257:79-83, 1999 (Academic Press).
Austin, et al., “Hypertriglyceridemia as a Cardiovascular Risk Factor”, Am. J. Cardiol. 81(4A):7B-12B, 1998 (Excerpta Medica, Inc.).
Baldo, et al., “The Adipsin-Acylation Stimulating Protein System and Regulation of Intracellular Triglyceride Synthesis”, J. Clin. Invest., 92:1543-1547; Sep. 1993 (The American Society for Clinical Investigation, Inc.).
Bartles, J.R. et al., “Biogenesis of the Rat Hepatocyte Plasma Membrane”, Methods Enzymol., 191:825-0841, 1990 (Academic Press).
Bihain, B.E., et al., “Characterization and Purification of the Lipolysis-Stimulated Receptor”, Elsevier Science B.V., pp. 465-470, 1995.
Bihane, B.E., et al., “Free Fatty Acids Activate a High-Affinity Saturable Pathway for Degradation of Low-Density Lipoproteins in Fibroblasts from a Subject Homozygous for Familial Hypercholesterolemia”, Biochemistry, 31:4628-4636, 1992 (American Chemical Society).
Brendel, V., et al., “Methods and Algorithms for Statistical Analysis of Protein Sequences”, Proc. Natl. Acad. Sci. USA, vol. 89:2002-2006, Mar. 1992.
Chen, W.J., et al., “NPXY, A Sequence Often Found in Cytoplasmic Tails, Is Required for Coated Pit-Mediated Internalization of the Low Density Lipoprotein Receptor”, J. Biol. Chem. 265:3116-3123, Feb. 25, 1990 (The American Society for Biochemistry and Molecular Biology, Inc.).
Cole-Strauss, et al., “Correction of the Mutation Responsible for Sickle Cell Anemia by an RNA-DNA Oligonucleotide”, Science, 273:1386-1389, Sep. 6, 1996.
Costet, P., et al., “Peroxisome Proliferator-Activated Receptor a-Isoform Deficiency Leads to Progressive Dyslipidemia with Sexually Dimorphic Obesity and Steatosis”, J. Biol. Chem., vol. 273, No. 45, 29577-29585, Nov. 6, 1998 (The American Society for Biochemistry and Molecular Biology, Inc.).
Davis, C.G., et al., “The J.D. Mutation in Familial Hypercholesterolemia: Amino Acid Substitution in Cytoplasmic Domain Impedes Internalization of LDL Receptors,” Cell, 45:15-24, Apr. 11, 1986 (Cell Press).
Everhart, J. E., “Weight Change and Obesity After Liver Transplantation: Incidence and Risk Factors”, Liver Transpl. Surg., vol. 4, No. 4:285-296, Jul. 1998.
Feeman, Jr., W.E., “Hypertriglyceridemia and Atherosclerosis”, Annals of Internal Medicine, vol. 128, No. 1, pp. 73-74, 1998.
Ghebrehiwet, et al., “Isolation, cDNA Cloning, and Overexpression of a 33-kD Cell Surface Glycoprotein that Binds to the Globular ‘Heads’ of C1q”, J. Exp. Med., 179:1809-1821; Jun. 1994 (The Rockefeller University Press).
Goldstein, J.L., et al., “Familial Hypercholesterolemia,” The Metabolic and Molecular Bases of Inherited Disease, vol. II, 7th Edition (Scriver, C.R., et al., ed), McGraw-Hill, New York, pp. 1981-2030, 1995.
Goldstein, et al., “Hyperlipidemia in Coronary Heart Disease”, J. Clin. Invest., 52:1533-1543, Jul. 1973.
Gura, et al., “Obesity Sheds its Secrets”, Science, 275:751-753, Feb. 7, 1997.
Hayward, et al., “The cDNA Sequenmce of Human Endothelial Cell Multimerin”. J. Biol. Chem., vol. 270, No. 31:18246-18251, Aug. 4, 1995 (The American Society for Biochemistry and Molecular Biology, Inc.).
Hennon, et al., “Structure, Sequence, and Chromosomal Location of the Gene for USF2 Transcription Factors in Mouse”, Genomics, 25:36-43 (1995) (Academic Press, Inc.).
Herz, J., et al., “Surface Locations and High Affinity for Calcium of a 500-kd Liver Membrane Protein Closely Related to the LDL-Receptor Suggest a Physiological Role as Lipoprotein Receptor”, European Molecular Biology Laboratory, 7:4119-4127 (1988) (IRL Press Limited, Oxford, England).
Honore, B., et al., “Cloning and Expression of a cDNA Covering the Complete Coding Region of the P32 Subunit of Human Pre-mRNA Splicing Factor SF2”, Gene, 134:283-287 (1993) (Elsevier Science Publishers B.V.).
Hu, et al., “AdipoQ is a Novel Adipose-Specific Gene Dysregulated in Obesity”, J. Biol. Chem. vol. 271, No. 18:10697-10703 (May 3, 1996).
Huetlinger M., et al., “Characteristics of Chylomicron Remnant Uptake into Ray Liver”, Clin. Biochem. 21:87-92 (1988).
Imagawa, et al., “Structure-Function Studies of Human Leptin”, J. Biol. Chem., vol. 273, No. 52:35245-35249, Dec. 25, 1998 (The American Society for Biochemistry and Molecular Biology, Inc.).
Karpe, F., et al., “Clearance of Lipoprotein Remnant Particles in Adipose Tissue and Muscle in Humans”, J. Lipid Res. 38:2335-2343 (1997).
Karpe, F. et al., “Magnitude of Alimentary Lipernia is Related to Intima-Media Thickness of the Common Carotid Artery in Middle-Aged Men”, Elsevier Science Ireland, 141:307-314, 1998.
Kersten, S., et al., “Peroxisome Proliferator?Activated Receptor aMediates the Adaptive Response to Fasting”, J. Clin. Invest., vol. 103, No. 11:1489-1
Bihain Bernard
Erickson Mary Ruth
Fruebis Joachim
Yen-Potin Frances
Genset S.A.
Saliwanchik Lloyd & Saliwanchik
Saoud Christine J.
LandOfFree
OBG3 globular head and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with OBG3 globular head and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and OBG3 globular head and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3528928